Saeko Nakajima
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 140 publications
Initial OX40-OX40L Signaling Promotes a Skin-Resident Memory T-Cell Reservoir in Atopic Dermatitis.
Journal: Allergy
Published: July 06, 2026
Corrigendum to 'Plasma proteomic profiles of patients with atopic dermatitis with moderate-to-severe pruritus treated with a single dose of nemolizumab' JID Innovations, Volume 6, Issue 3, May 2026, 100457.
Journal: JID innovations : skin science from molecules to population health
Published: April 20, 2026
Dupilumab Treatment Provides Multidimensional Benefits in Patients with Prurigo Nodularis.
Journal: Dermatology and therapy
Published: March 03, 2026
PATHOPHYSIOLOGICAL AND CLINICAL SIGNIFICANCE OF IL-31 IN ALLERGIC DISEASES
Journal: Arerugi = [Allergy]
Published: February 11, 2026
Guidelines for the Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis 2025 Supplement.
Journal: The Journal of dermatology
Published: November 30, 2025
IL-31 blockade elevates thymus and activation-regulated chemokine by lifting LAMP3+CD1c+ mature dendritic cells from calcitonin gene-related peptide-calcitonin receptor-like neuroimmune suppression in atopic dermatitis.
Journal: The Journal of allergy and clinical immunology
Published: October 23, 2025
Plasma proteomic profiles of patients with atopic dermatitis with moderate-to-severe pruritus treated with a single dose of nemolizumab.
Journal: JID innovations : skin science from molecules to population health
Published: September 30, 2025
A peripheral neurons-basophil axis drives heat-killed Staphylococcus aureus-induced dermatitis through toll-like receptor 2 signaling pathway.
Journal: The Journal of investigative dermatology
Published: September 22, 2025
Stevens-Johnson Syndrome Induced by Radiotherapy Alone: A Rare and Well-Documented Case Without Concomitant Drug Exposure.
Journal: International journal of dermatology
Published: August 26, 2025
Exploring Patient and Public Involvement and Engagement in Allergy Research: Cross-Disease and Cross-Stakeholder Perspectives in Japan.
Journal: Allergy
Published: July 27, 2025
Efficacy and Safety of Etanercept in Japanese Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Unresponsive to Systemic Steroid Therapy: A Multicenter, Open-Label, Single-Arm Study.
Journal: The Journal of dermatology
Published: May 30, 2025
Last Updated: 09/26/2026